C
Complete Genomics
An established technology leader in whole human genome sequencing
About Complete Genomics
Complete Genomics is a life sciences company that has developed and commercialized a DNA sequencing platform for human genome sequencing and analysis. The company provides comprehensive sequencing solutions catering to both the research and healthcare sectors.
Read full description
Their core offering is a high-performance sequencing technology with industry-leading accuracy and variant detection. This technology is utilized for whole genome sequencing (WGS), exome sequencing, and other genomic analysis services. The company's business model is centered on the sale of these sequencing solutions and services to a client base that includes research institutions and healthcare providers.
As a subsidiary of MGI, Complete Genomics has a significant U.S. manufacturing footprint and is actively working on diversifying its supply chain and expanding its Next-Generation Sequencing (NGS) capabilities. The company engages in strategic collaborations and partnerships to further its reach and technological advancements in the genomics field.
At a glance
- Status
- Acquired
- Founded
- 2006
- Headquarters
- Mountain View, United States
- Employees
- 240
- Open positions
- 7
- Dealroom signal
- 70.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Complete Genomics.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Feb 2026 | $50M | — | Swiss Rockets | ↗ |
| ACQUISITIONOther financing | Sep 2012 | $118M | $118M | Building Global Innovators | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Complete Genomics is 7.7K monthly website visits, down 6.1% over the last three months. Complete Genomics's team grew 2.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 AntegenesGenetic tests for personalized cancer risk prevention |
Tartu, Estonia | Operational | 11 | $3.4M | $7M |
 FemtogenixDNA-interactive payloads for antibody-drug conjugates |
St Albans, United Kingdom | Operational | |||
 GeneCast BiotechnologyIt is a Beijing cancer diagnosis company |
Haidian, China | Operational | |||
 AnchorDxAnchorDx is a precision medicine firm |
Guangzhou, China | Operational | |||
 GeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world |
Cambridge, United Kingdom | Operational | |||
 Atossa GeneticsHealthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients |
Seattle, United States | Operational | |||
 PrevnosBiotechnology company operating within the in vitro diagnostics sector |
Jersey City, United States | Operational | |||
 Shield BioFighting antibiotic resistance with genomics |
Santa Clara, United States | Closed |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- OPOVP Venture Partners
Enterprise Partners
Series B and later6 investors entered at this stage
OrbiMed
EW Healthcare Partners
Highland Capital Partners- PPProspect Venture Partners
Essex Woodlands Health Ventures
Sands Capital Management
Other known investors2 additional known investors
Building Global Innovators
Swiss Rockets
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Complete Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Complete Genomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.